BioGenerator congratulates its portfolio company, Adarza BioSystems, on closing a $6.8 million Series A financing round and its plans to expand its St. Louis presence. BioGenerator, an entrepreneurial support and […]
Read MoreThe BioGenerator has been recognized as a Center of Best Practice in the second annual “Signs of Competitiveness in the America’s” report from the Inter- American Competitiveness Network under the […]
Read MoreBioGenerator was named a winner of SSTI’s 2013 “Excellence in TBED” (technology-based economic development) award, recognizing BioGenerator and its programs as national models for investing in science, technology and innovation […]
Read MoreFour additional Entrepreneurs In Residence (EIRs) have joined the BioGenerator, bringing the organization’s roster of EIRs to 12 – up from five last summer. The EIRs will support the creation […]
Read MoreBioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business […]
Read MoreBioGenerator – the non-profit venture development organization of BioSTL – recently closed on an investment in Antegrin Therapeutics through its i6 Project Fund. The investment will allow Antegrin to select […]
Read MoreBioGenerator – the non-profit venture development organization of BioSTL – recently closed on a Spark Fund investment in Tansna Therapeutics, Inc., to support further commercialization of the company’s epilepsy drugs […]
Read MoreDr. Cheryl Watkins-Moore has joined as an Entrepreneur-in- Residence (EIR) with the BioGenerator – the non-profit venture development organization of BioSTL – to create, lead, and support new bioscience companies […]
Read More